What You Should Know:
– 23andMe Holding Co. (Nasdaq: ME), a genetics and biopharmaceutical company, announced The U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for 23ME-01473 (referred to…
Continue Reading
By Hannah Nelson
January 31, 2024 – While generative AI shows promise for EHR data summarization, using large language models (LLMs) to summarize clinical data brings risks that are not clearly covered by existing Food and…
Continue Reading
What You Should Know:
– Deliberate AI, a digital health company harnessing AI to revolutionize mental health assessment, has secured a major milestone in its mission. The U.S. Food and Drug Administration (FDA) has selected…
Continue Reading
What You Should Know:
– Thirona, a pioneer in AI-powered lung analysis, received a major boost for its cutting-edge technology LungQ™ with the U.S. Food and Drug Administration (FDA) 510(k) clearance for its latest update,…
Continue Reading
What You Should Know:
Medtronic, a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its Percept™ RC Deep Brain Stimulation (DBS) system.The rechargeable neurostimulator is the latest…
Continue Reading
The U.S. Food and Drug Administration gave De Novo clearance to Techsomed’s BioTraceIO, which leverages a computational algorithm to analyze ultrasound images captured during liver ablation treatment for use with its artificial intelligence-powered ablation treatment…
Continue Reading
The Government Accountability Office has completed its review of cybersecurity in medical devices under the Consolidated Appropriations Act of 2023 and recommended the commissioner of food and drugs at the U.S. Food and Drug…
Continue Reading
What You Should Know:
– Smileyscope™, a pioneer in virtual reality (VR) therapeutic solutions, has received Class II clearance from the U.S. Food and Drug Administration (FDA) for its Smileyscope™ Therapy system.
– The FDA clearance…
Continue Reading
The integration of AI in the healthcare industry could yield remarkable savings for the United States, projected at a staggering US$360 billion. This insight emerged in a report by researchers from McKinsey and Harvard….
Continue Reading
Shareholders of KOSDAQ-listed Lunit have recently participated in the company’s recent capital raise, paying-in $150 million to fund its development of “next-generation” products and further expansion in the West. Meanwhile, the AI cancer diagnostics solutions…
Continue Reading
